Valensa gets patents for FlexPro

Florida-based Valensa International said the US Patent and Trademark Office awarded it two new patents — its 17th and 18th in this area — “locking down” patent protection for the core ingredients related to its FlexPro MD and FlexPro ES dietary formulations.

“In clinical trials, these dietary formulations for joint health were shown to be 3-5 times more effective in relieving joint discomfort than a standard commercial formulation of glucosamine and chondroitin,” said Valensa.